BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 9104811)

  • 1. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model.
    Ehl S; Hombach J; Aichele P; Hengartner H; Zinkernagel RM
    J Exp Med; 1997 Apr; 185(7):1241-51. PubMed ID: 9104811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
    Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
    J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
    Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences.
    Zimmermann C; Prévost-Blondel A; Blaser C; Pircher H
    Eur J Immunol; 1999 Jan; 29(1):284-90. PubMed ID: 9933110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited in vivo reactivity of polyclonal effector cytotoxic T cells towards altered peptide ligands.
    Bättig P; Saudan P; Storni T; Gallimore A; Bachmann MF
    Microbes Infect; 2005 Apr; 7(4):729-37. PubMed ID: 15857805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes.
    Slifka MK; Shen H; Matloubian M; Jensen ER; Miller JF; Ahmed R
    J Virol; 1996 May; 70(5):2902-10. PubMed ID: 8627765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells.
    Wang B; Maile R; Greenwood R; Collins EJ; Frelinger JA
    J Immunol; 2000 Feb; 164(3):1216-22. PubMed ID: 10640733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
    Yang HY; Dundon PL; Nahill SR; Welsh RM
    J Immunol; 1989 Mar; 142(5):1710-8. PubMed ID: 2537363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
    Nahill SR; Welsh RM
    J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricted V-segment usage in T-cell receptors from cytotoxic T lymphocytes specific for a major epitope of lymphocytic choriomeningitis virus.
    Yanagi Y; Maekawa R; Cook T; Kanagawa O; Oldstone MB
    J Virol; 1990 Dec; 64(12):5919-26. PubMed ID: 1700830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.
    Selin LK; Nahill SR; Welsh RM
    J Exp Med; 1994 Jun; 179(6):1933-43. PubMed ID: 8195718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells efficiently induce protective antiviral immunity.
    Ludewig B; Ehl S; Karrer U; Odermatt B; Hengartner H; Zinkernagel RM
    J Virol; 1998 May; 72(5):3812-8. PubMed ID: 9557664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of virus-specific antibody production by CD8+ class I-restricted antiviral cytotoxic T cells in vivo.
    Moskophidis D; Pircher H; Ciernik I; Odermatt B; Hengartner H; Zinkernagel RM
    J Virol; 1992 Jun; 66(6):3661-8. PubMed ID: 1583725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens.
    Lenz LL; Butz EA; Bevan MJ
    J Exp Med; 2000 Oct; 192(8):1135-42. PubMed ID: 11034603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences of cytotoxic T lymphocyte interaction with major histocompatibility complex class I-expressing neurons in vivo.
    Rall GF; Mucke L; Oldstone MB
    J Exp Med; 1995 Nov; 182(5):1201-12. PubMed ID: 7595191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory.
    Pinschewer DD; Ochsenbein AF; Odermatt B; Brinkmann V; Hengartner H; Zinkernagel RM
    J Immunol; 2000 Jun; 164(11):5761-70. PubMed ID: 10820254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-induced activation of self-specific TCR alpha beta CD8 alpha alpha intraepithelial lymphocytes does not abolish their self-tolerance in the intestine.
    Saurer L; Seibold I; Rihs S; Vallan C; Dumrese T; Mueller C
    J Immunol; 2004 Apr; 172(7):4176-83. PubMed ID: 15034030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen.
    Oehen S; Waldner H; Kündig TM; Hengartner H; Zinkernagel RM
    J Exp Med; 1992 Nov; 176(5):1273-81. PubMed ID: 1402673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.